Cargando...

Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma

BACKGROUND: Improving outcomes of patients with glioblastoma (GBM) represents a significant challenge in neuro-oncology. We undertook a systematic review of key parameters of phase II and III trials in GBM to identify and quantify the impact of trial design on this phenomenon. METHODS: Studies betwe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Adv
Main Authors: Balasubramanian, Adithya, Gunjur, Ashray, Hafeez, Umbreen, Menon, Siddharth, Cher, Lawrence M, Parakh, Sagun, Gan, Hui Kong
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850118/
https://ncbi.nlm.nih.gov/pubmed/33543145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa171
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!